08:25 EST Day One Biopharmaceuticals (DAWN) trading halted, news pending
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAWN:
- Day One jumps 26% to $12.59 after Betaville mention
- Day One Biopharmaceuticals up 11% after rumor highlighted in Betaville blog
- Day One Biopharmaceuticals: Ojemda Uptake, Strong 2026 Guidance, and Underappreciated Emi‑Le Catalyst Support Buy Rating
- Day One Highlights OJEMDA’s EMA Progress, Updates Strategy
- Day One Biopharmaceuticals price target raised to $30 from $29 at Wedbush